跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
FluMist Quadrivalent influenza virus vaccine nasal spray applicator, live attenuated 10000000 FFU/strain/0.2 mL dose - TGA Drug Approval Details
Approvals
/
TGA
/
FluMist Quadrivalent influenza virus vaccine nasal spray applicator, live attenuated 10000000 FFU/strain/0.2 mL dose
Approved
STANDARD
FluMist Quadrivalent influenza virus vaccine nasal spray applicator, live attenuated 10000000 FFU/strain/0.2 mL dose
AstraZeneca Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
396e3189610012d7
Company
AstraZeneca Pty Ltd
Type
Standard
Approval Details
Approval Id
396e3189610012d7
Product Name
FluMist Quadrivalent influenza virus vaccine nasal spray applicator, live attenuated 10000000 FFU/strain/0.2 mL dose
Artg Id
244892
Artg Name
FluMist Quadrivalent influenza virus vaccine nasal spray applicator
Sponsor
AstraZeneca Pty Ltd
Company Detail Path
/organization/astrazeneca-pty-ltd
Artg Date
2016-10-18
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Product Information
https://medical-cdn.nocode.com/drug_tga/b49ff31b2164506481ad57846eaa5ee2.pdf
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
396e3189610012d7
Type
Standard
Back to TGA Approvals